株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

鳥居薬品:製品パイプライン分析

Torii Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014

発行 Global Markets Direct 商品コード 293990
出版日 ページ情報 英文 26 Pages
即納可能
価格
本日の銀行送金レート: 1USD=114.77円で換算しております。

2016年12月31日まで 年末キャンペーン割引: Global Markets Direct社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
鳥居薬品:製品パイプライン分析 Torii Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014
出版日: 2014年06月15日 ページ情報: 英文 26 Pages
概要

当レポートでは、鳥居薬品における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

鳥居薬品の基本情報

鳥居薬品の概要

  • 主要情報
  • 企業情報

鳥居薬品:R&Dの概要

  • 主な治療範囲

鳥居薬品:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品
  • パートナー製品
    • パートナー製品/併用療法モダリティ

鳥居薬品:パイプライン製品の概況

  • 最終段階にあるパイプライン製品
    • 登録前の製品/併用療法モダリティ
    • 第III相にある製品/併用療法モダリティ
  • 治験段階にあるパイプライン製品
    • 第I相にある製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 創薬中の製品/併用療法モダリティ

鳥居薬品:薬剤プロファイル

  • MK-8237
  • TO-206
  • スギ花粉アレルギー用ワクチン

鳥居薬品:パイプライン分析

  • 投与経路別
  • 分子タイプ別

鳥居薬品:最近のパイプライン動向

鳥居薬品:本社と子会社の所在地

付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC05015CDB

Global Markets Direct's, 'Torii Pharmaceutical Co., Ltd. - Product Pipeline Review - 2014', provides an overview of the Torii Pharmaceutical Co., Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Torii Pharmaceutical Co., Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Torii Pharmaceutical Co., Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Torii Pharmaceutical Co., Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Torii Pharmaceutical Co., Ltd.'s pipeline products

Reasons to buy

  • Evaluate Torii Pharmaceutical Co., Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Torii Pharmaceutical Co., Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Torii Pharmaceutical Co., Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Torii Pharmaceutical Co., Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Torii Pharmaceutical Co., Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Torii Pharmaceutical Co., Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Torii Pharmaceutical Co., Ltd. Snapshot
    • Torii Pharmaceutical Co., Ltd. Overview
    • Key Information
    • Key Facts
  • Torii Pharmaceutical Co., Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Torii Pharmaceutical Co., Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • Torii Pharmaceutical Co., Ltd. - Pipeline Products Glance
    • Torii Pharmaceutical Co., Ltd. - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • Torii Pharmaceutical Co., Ltd. - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • Torii Pharmaceutical Co., Ltd. - Early Stage Pipeline Products
      • Discovery Products/Combination Treatment Modalities
  • Torii Pharmaceutical Co., Ltd. - Drug Profiles
    • allergenic pollen extract of timothy
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • MK-8237
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • TO-206
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Vaccine for Cedar Pollen Allergy
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Torii Pharmaceutical Co., Ltd. - Pipeline Analysis
    • Torii Pharmaceutical Co., Ltd. - Pipeline Products by Route of Administration
    • Torii Pharmaceutical Co., Ltd. - Pipeline Products by Molecule Type
  • Torii Pharmaceutical Co., Ltd. - Recent Pipeline Updates
  • Torii Pharmaceutical Co., Ltd. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Torii Pharmaceutical Co., Ltd., Key Information
  • Torii Pharmaceutical Co., Ltd., Key Facts
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Indication, 2014
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
  • Torii Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Torii Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014
  • Torii Pharmaceutical Co., Ltd. - Partnered Products/ Combination Treatment Modalities, 2014
  • Torii Pharmaceutical Co., Ltd. - Pre-Registration, 2014
  • Torii Pharmaceutical Co., Ltd. - Phase III, 2014
  • Torii Pharmaceutical Co., Ltd. - Phase I, 2014
  • Torii Pharmaceutical Co., Ltd. - Discovery, 2014
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Route of Administration, 2014
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Molecule Type, 2014
  • Torii Pharmaceutical Co., Ltd. - Recent Pipeline Updates, 2014
  • Torii Pharmaceutical Co., Ltd., Other Locations

List of Figures

  • Torii Pharmaceutical Co., Ltd. - Pipeline by Top 10 Indication, 2014
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Stage of Development, 2014
  • Torii Pharmaceutical Co., Ltd. - Monotherapy Products in Pipeline, 2014
  • Torii Pharmaceutical Co., Ltd. - Partnered Products in Pipeline, 2014
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Top 10 Route of Administration, 2014
  • Torii Pharmaceutical Co., Ltd. - Pipeline by Top 10 Molecule Type, 2014
Back to Top